Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1129357.RAHJJRDPw0TEXXw1QF60rBJVeiF5stM51u8kz_nfk2U1g130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1129357.RAHJJRDPw0TEXXw1QF60rBJVeiF5stM51u8kz_nfk2U1g130_assertion type Assertion NP1129357.RAHJJRDPw0TEXXw1QF60rBJVeiF5stM51u8kz_nfk2U1g130_head.
- NP1129357.RAHJJRDPw0TEXXw1QF60rBJVeiF5stM51u8kz_nfk2U1g130_assertion description "[Primary tumors of ganetespib-treated mice had significantly reduced levels of HIF-1? (but not HIF-2?) protein and of HIF-1 target gene mRNAs encoding proteins that play key roles in angiogenesis, metabolism, invasion, and metastasis, thereby providing a molecular basis for observed effects of the drug on the growth and metastasis of triple-negative breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1129357.RAHJJRDPw0TEXXw1QF60rBJVeiF5stM51u8kz_nfk2U1g130_provenance.
- NP1129357.RAHJJRDPw0TEXXw1QF60rBJVeiF5stM51u8kz_nfk2U1g130_assertion evidence source_evidence_literature NP1129357.RAHJJRDPw0TEXXw1QF60rBJVeiF5stM51u8kz_nfk2U1g130_provenance.
- NP1129357.RAHJJRDPw0TEXXw1QF60rBJVeiF5stM51u8kz_nfk2U1g130_assertion SIO_000772 24248265 NP1129357.RAHJJRDPw0TEXXw1QF60rBJVeiF5stM51u8kz_nfk2U1g130_provenance.
- NP1129357.RAHJJRDPw0TEXXw1QF60rBJVeiF5stM51u8kz_nfk2U1g130_assertion wasDerivedFrom befree-2016 NP1129357.RAHJJRDPw0TEXXw1QF60rBJVeiF5stM51u8kz_nfk2U1g130_provenance.
- NP1129357.RAHJJRDPw0TEXXw1QF60rBJVeiF5stM51u8kz_nfk2U1g130_assertion wasGeneratedBy ECO_0000203 NP1129357.RAHJJRDPw0TEXXw1QF60rBJVeiF5stM51u8kz_nfk2U1g130_provenance.